Researchers from NAL provide objective measures that characterize the acoustic performance of AirPods Pro headphones. The results suggest that, while differences to traditional hearing aids exist, the device's Headphone Accommodations provide amplification to help people with mild-to-moderate hearing loss hear sounds more easily and allow them to experience the benefits of amplification.
GN announced the extension of its Jabra Enhance line of hearing enhancement solutions designed to “help users hear more from life.” GN “brings together the convenience of true wireless earbuds with advanced hearing technology to alleviate unaddressed user needs and enable millions of people to take a first step on their hearing health journey,” according to the company's announcement.
During its annual Worldwide Developers Conference (WWDC) on June 7, Apple announced new speech-in-noise enhancement capabilities in iOS 15 called “Conversation Boost,” which uses computational audio and beamforming microphones for use in Apple AirPod Pros.
With the rise of telecare and DIY/self-fit hearing devices (for at least milder hearing losses), hearing healthcare stakeholders will need to determine how and in what markets they do business.
Read More
The IQbuds² PRO has received FDA classification as a Class 2 medical device. “Utilizing Nuheara’s connected hearing technology platform, the company’s aspiration is to create an end-to-end hearing healthcare company by efficiently delivering hearing products, accessories, and services across the Hearables, Medical Device, and OTC markets,” says Nuheara CEO Justin Miller.
Read More
Unlike conventional hearing aids, Earlens “doesn’t amplify sound with a speaker but, instead, it directly stimulates the eardrum.”
Read More
According to Nuheara, what makes IQbuds² MAX unique is the EarID clinically certified personalization system embedded in the IQbuds App. EarID helps allow consumers “to self-assess, self-fit, and auto calibrate their IQbuds² MAX to their own personal hearing profile using National Acoustic Labs NAL-NL2 hearing aid prescription algorithms.”
Read More
Eargo reported that net revenue was $18.2 million for the third quarter of 2020, compared to $7.7 million in the third quarter of 2019. The company says the increase was driven by an increase in consumer adoption of the Eargo hearing aid system and a decrease in sales return accrual rate.
Read More
Olive Pro helps customizes your hearing by “optimizing audio frequencies to your sound profile, while automatically cancelling background noises and feedback.”
Read More
Their latest letter follows a December 2019 letter in which they also urged the FDA to finalize rules for OTC hearing aids.
Read More
Nicholas Reed, PhD, and his colleagues at Johns Hopkins have been involved in some extremely exciting research on personal sound amplification products (PSAPs) and over-the-counter (OTC) devices, as well as cognition and hearing loss. Douglas Beck, AuD, interviews Dr Reed about these topics, as well as the group’s recent work on the ACHIEVE study.
Read More
Eargo raised $141 million during its recent IPO, according to an article on the “Forbes” website, “sending shares up 87% on its first day of public trading.”
Read More
For about $15-$20, Bhamla says that anyone can recreate the device at home with online blueprints, a soldering iron, and easy-to-find parts.
Read More
Exceptional sound quality—above all the other “bells and whistles” that the latest generation of hearing aids provide (eg, connectivity, remote fine-tuning, hands-free phone calls, motion-sensors and tap controls, virtual assistants, etc)—may turn out to be THE final hurdle for convincing younger people with milder hearing losses to purchase a hearing aid.
Read More
The recent announcement that musician John Legend has been appointed the Chief Music Officer of meditation and mindfulness tech brand Headspace is timely considering the advent of the “Hearables Revolution,” a “perfect storm” of new audio and biometric capabilities for wearable devices for the ear, according to an article in “Forbes.”
Read More
A spokesperson for the FDA Center for Devices and Radiological Health has said that it’s likely that the deadline for the release of guidelines on the “OTC Hearing Aid Act” may be pushed back due to the coronavirus, according to Forbes.
Read More
Eargo announced the closing of a $71 million equity financing, led by new co-investors Gilde Healthcare and Longitude Capital, with existing investors New Enterprise Associates (NEA), the Charles and Helen Schwab Foundation, and Nan Fung Life Sciences, also participating in the round.
Read More
OTC and DTC hearing devices will not be confined only to the United States; they are destined to influence hearing care globally. This Delphi survey systematically identifies perceptions among hearing care professionals in the UK toward new and emerging technologies and delivery options for adults with hearing loss.
Read More